A study to assess mass drug administration of DEC for filaria control in district Satna, Madhya Pradesh: a mid term assessment
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20180785Keywords:
Midterm assessment, Mass drug administration, FilariaAbstract
Background: Lymphatic filariasis is a major public health problem which is caused by Wuchereria Bancrofti and Brugia Malai. The disease is endemic in 250 districts in 20 states and UTs. In India national health policy 2002 envisages elimination of lymphatic filariasis by 2015. Important strategy for elimination of lymphatic filariasis is through annual mass drug administration of single dose of DEC for 5 year or more to the eligible population. Present cross sectional study was carried out to assess drug compliance after mass drug administration of DEC and the factors responsible for poor compliance among the population of Satna district of MP.
Methods: The present study was a cross-sectional study which was carried out in filarial endemic Satna district. In this district 120 houses from 3 CHC & one urban ward was randomly selected. 30 households each from 3 rural and one urban site were interviewed related to MDA for DEC.
Results: Coverage of tablet distribution in Satna was 90.9%. Consumption of drug among the people who received the drug was 87.97%, while the total effective consumption was 79.9%. Drug distributors ensured consumption of drug in only 16.9%.
Conclusions: Focus of MDA is primarily to mere distribution of drug. There is need to give emphasis on consumption of drug, health education, common side effects and its management in order to increase effective coverage rate.
Metrics
References
World health organization. November 2004 Lymphatic filariasis: progress of disability prevention activities. Weekly epidemiological record. Available at http://www.who.int/wer/2004/en/wer7947.pdf. Accessed at 02 January 2018.
Govt. of India (2016), annual Report 2015-16, Ministry of health and family welfare, New Delhi.
National Vector Borne Disease Control Programme. Disease, all about filaria. Available at http://www.nvbdcp.gov.in/filariasis.html. Accessed at 02 January 2018.
National Vector Borne Disease Control Programme. Annual-report-NVBDCP-2012. Available at http://www.nvbdcp.gov.in/Doc/Annual-report-NVBDCP-2012.pdf. Accessed at 02 January 2018.
Vector control research centre. Indian council of medical research Lymphatic Filariasis 2014 Available at http://vcrc.res.in/forms/modulelist.aspx?lid=2134&mid=25. Accessed at 02 January 2018.
National Vector Borne Disease Control Programme. Guideline on elimination of lymphatic filariasis in India. Implementation of mass drug administration Available at http://nvbdcp.gov.in/doc/guidelines-filariasis-elimination-india.pdf accessed at 02 January 2018.
World Health Organization. Regional Strategic Plan for Elimination of Lymphatic Filariasis (2004-2007) 2004; 1-2 Available from: http://www.searo.who.int/LinkFiles/New LymphaticFilariasis_Regional_Strategic_Plan_LF 2004-2007. Accessed at 02 January 2018.
Stolk WA, Swaminathan S, van Oortmarssen GJ, Das PK, Habbema JDF. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis. 2003;188:1371–81.
Shinde M, Saraf Y, Joshi A. Mid Term Assessment of Mass Drug Administration in Lymphatic Filariasis Endemic area of Damoh and Sagar District of Madhya Pradesh. J Evol Med Dental Sci. 2015;4(24):4121-7.
Bansal M, Tiwari R, Prasad P, Arya RS, Gupta A. A midterm assessment and evaluation of coverage and compliance of mass drug administration programme 2012 for elimination of lymphatic filariasis in Madhya Pradesh, India. Int J Res Health Sci. 2014;2(1):94-100.
Kumar P, Prajapati PB, Saxena D, Kavishwar AB, Kurian G. An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of Gujarat. Indian J Community Med. 2008;33:38-42.
Downloads
Published
How to Cite
Issue
Section
